Skip to content
PQMS
  • Homepage
  • Products
  • About Us
  • Blog
  • Contact us
Login
Book demo
  • From Qualification to PPQ: The Bigger Picture of Paperless Validation

    From Qualification to PPQ: The Bigger Picture of Paperless Validation

    When organisations discuss paperless validation, Computer System Validation (CSV) is almost always the first topic on the table. This comes as no surprise — electronic hardware and software have become deeply embedded in every facet of modern manufacturing. Yet, while digital systems serve an important supporting function, they are not what ultimately produces a product. The most critical component in any manufacturing operation is the equipment itself. Without equipment, nothing gets made. That is why paperless validation should focus strongly on the equipment level.

    Whether introducing new equipment or modifying an existing asset, the end goal seems to be always the same: to qualify the equipment or update its qualification records. In the case of an existing piece of equipment, this might involve changes to the PLC logic or the replacement and upgrade of key components.  But is that enough?

    What matters most when teams make these changes is not simply whether they have updated the qualification records correctly. Far more important is the effect these changes have had on process parameters. Regulators and auditors are primarily concerned with whether manufacturing and cleaning processes continue to perform consistently — whether there is variation within a batch and from one batch to the next.  That is the question of interest.

    This article addresses an often-missed link in this chain: the data that the process validation team needs after the equipment qualification team completes its work. This handover of critical information is, in reality, the most important activity in the entire process.  Because it determines whether the process remains compliant. One cannot operate equipment in a range that was not qualified. 

    Process Paramters

    Process parameters are not merely operational settings — they are the critical link between equipment performance and product quality. They have a direct and measurable effect on the Critical Quality Attributes (CQAs) that define whether a drug product meets its specification. A shift in even 1 process parameter, however small, can alter the quality profile of the final product. This is precisely why teams must carefully assess every equipment modification and consider its downstream impact on process parameters and, ultimately, patient safety.

    The same principle applies when purchasing new equipment. Does the new equipment truly match the existing one? Teams must analyse and document this comparison before moving forward with procurement.

    Consider a real example. A site plans to replace an old granulation mixer with a new model featuring an updated, more efficient bowl design and a PLC-controlled mixing cycle.

    The new mixer requires equipment qualification before the site can put it into production. But qualification should not be the starting point. Before defining the additional equipment and software qualification steps, the team should ask at least two questions to determine what it needs to demonstrate through PPQ and CV runs to ensure the product meets its specifications, both in-process and in the finished product.

    1. Is the new equipment identical to the equipment it will replace? If differences exist, what are they? How could those differences affect product quality? For example, has the bowl geometry changed in a way that alters the product-contact surface area or mixing dynamics?
    2. Will the site purchase the equipment “off the shelf,” or will the supplier customise it?

    The new bowl design may alter the fundamental fluid dynamics and mass movement within the mixer. As a result, the existing ranges for critical process parameters such as mixing speed, shear profile, mixing time to endpoint, and torque curves may no longer remain valid. The team would therefore need to repeat PPQ runs on the new equipment to demonstrate that the process still meets the required product specifications.

    A change in PLC logic could also fundamentally alter how the equipment controls and sequences the process. The original PPQ runs used a specific set of automated controls, including defined ramp rates, hold times, interlocks, alarm thresholds, and parameter sequencing. These controls consistently delivered product that met its CQAs.

    If the new PLC logic manages these same parameters differently — perhaps through different control algorithms, tighter or wider deadbands, altered timing sequences, or different response characteristics to process deviations — the previously validated process no longer represents the new operating conditions. The team must therefore conduct new PPQ runs to demonstrate that the new control logic, while governing the same critical process parameters, still produces a product that consistently meets its drug product specifications, batch after batch. Parameters, still produces a product that consistently meets its drug product specifications, batch after batch.

    3 Runs Completed Successfully – Tell us more about the process

    Three successful PPQ runs may satisfy the immediate qualification requirement, but they do not provide the full picture. They represent a limited snapshot — a demonstration that the process can produce compliant product under controlled conditions on three occasions. What they cannot tell us is how tightly the product specification remains within tolerance over time. This is precisely why Continued Process Verification (CPV) exists — to confirm that the results demonstrated during the three PPQ runs remain consistent at batch fifty, batch one hundred, and beyond. Without sustained monitoring during the CPV stage, those three successful runs can create false assurance while leaving the risk of slow, undetected drift from the drug product specification unaddressed.

    The team must not only monitor the process after PPQ runs; it must also monitor the equipment and the PLC logic that controls it. PLC logic does not remain static. Software updates, firmware patches, sensor recalibration, and even subtle electrical degradation can change how the control system behaves over time. A timing sequence can drift by milliseconds, maintenance can inadvertently overwrite an alarm threshold, or a control loop can respond differently to input signals — and any of these changes can shift process parameters without triggering a single deviation.

    Equally, the physical equipment is subject to wear and tear that no PLC can detect — bowl surfaces that degrade over time, impeller blades that erode and alter shear profiles, seals that harden and introduce dead spots, or contact surfaces that pit and roughen, changing both product interaction and cleanability. If the organisation monitors only the product and the process but neglects the equipment’s control logic and its physical condition, it creates a blind spot where the root cause of a future quality failure — whether digital or mechanical — will remain invisible until it manifests as out-of-specification product in the hands of the patient.

    Paperless Validation Must Evolve Too

    If validation is a lifecycle, then paperless validation must evolve with it. The objective is not simply to replace paper with electronic records. It is to make validation easier to manage throughout its entire lifecycle — from initial qualification through process validation, change control, monitoring and ongoing verification.

    This means paperless validation must look beyond electronic components, software, and PLC logic alone. The equipment in its entirety must be qualified — its mechanical systems, its control logic, its physical condition and its interaction with other equipment. This is not a novel concept. ISPE Baseline Guide Volume 5 on Commissioning and Qualification makes this point clearly: qualification should encompass the complete equipment system, not just its individual automated elements. A paperless approach that captures only the digital layer while ignoring the physical asset beneath it is not simplifying the lifecycle — it is leaving critical gaps in it.

    Positioning PQMS Suite

    This is where an integrated platform such as Quascenta’s PQMS Suite can support the broader validation lifecycle.

    ValDoc Pro supports all qualification & computer system validation activities; eProcess Pro manages PPQ runs and CPV runs; eResidue Pro supports cleaning process management; eLog Pro enables electronic logging and recording of routine operational activities to support ongoing monitoring and control; and QMS Pro manages the change control, CAPAs, and non-conformances that changes like this can trigger.

    Together, these capabilities allow organisations to move beyond simply converting paper-based validation tasks into electronic format. Instead, they create a connected digital environment that brings qualification, process validation, cleaning validation, change control, and ongoing monitoring together within one coherent, living system.

    ravi

    September 1, 2026
    Uncategorized
    csv, digital transformation, digitilization, Equipment Qualification, paperless validation, Pharmaceutical Validation, Quality Assurance
  • One-Size-Fits-All Paperless Validation – Is It Really Fit for Use?

    One-Size-Fits-All Paperless Validation – Is It Really Fit for Use?

    Synopsis:

    Popular  validation tools have a basic flaw – these applications were designed to only carry out qualification activities.  This article emphasises the differences between qualification and validation, and why for process and cleaning validation/monitoring, such “paperless validation” applications offer little more value than a document management system. An efficient digital validation platform has to be a suite of applications each performing what it has to be designed for, qualification, manufacturing process management, cleaning process management separately,  but still integrated so as to provide a smooth flow of data. 

    Introduction

    No manufacturing sector can survive without a relentless focus on quality—because the very essence of manufacturing is to produce consistent and standardized product.  Any lapse in quality in pharmaceutical industry leads to regulatory scrutiny, fines, damaged reputations, and ultimately business failure. 

    In pharmaceutical manufacturing, the regulatory expectation is that the process be in “a state of control”.  And historically we “validate” processes, e.g., manufacturing, packaging, cleaning or QC method.  The core objective of validation is to demonstrate document consistent, controlled performance over time.  Validation is more than a regulatory requirement—it is the foundation of operational consistency, product quality and most importantly.

    As digital “validation” solutions flood the market, the expectation is that these digital tools do more than merely replicating paper processes in electronic form – that they will enable smarter, more integrated validation approaches that align with regulatory requirements and operational needs. But do they deliver on this promise?

    This article explores the differences between validation and qualification, and why the “one-size-fits-all” approach towards  “validation” is an idea that falls well short of customer expectations. 

    Let’s Clarify the Basics

    Before delving deeper, it is crucial to differentiate between the two terms that are often confused: qualification and validation.

    • The expectation from Qualification is that the equipment, utilities, instruments, software used in a GMP environment have been installed correctly and function as intended.
    • Expectation from Validation is to show that the processes are “in a state of control”. 

    In simple terms, Qualification answers, “Does that entity work as per our requirement?” while Validation dives deeper to explore, “Can we get a reliable and consistent product?”

    Understanding Qualification

    The User Requirements Specification (URS) is usually the first document created when a new entity/asset is being planned, detailing the requirements, including business, compliance, and operational requirements.  This activity is done by stakeholders who are either responsible or accountable for that asset/entity.

    The selected vendor(s), or the internal resource where applicable, respond with a Functional Specification (FS) detailing how the requirements in the User requirement will be met.

    The specific test script document requirements vary depending on what is being qualified. However, the intent remains the same: to demonstrate, through test scripts, that the User Requirement Specification (URS) requirements have been met. These test scripts may be documented in Factory Acceptance Tests (FAT), Installation Qualification (IQ), Operational Qualification (OQ), Site Acceptance Tests (SAT), or Performance Qualification (PQ). The selection of which of these to include depends on the particular asset or system being qualified.

    A Traceability Matrix document is then put together mapping each requirement to the corresponding tests, detailing the user requirement ID and the test script ID. This matrix provides clear visibility of how every user requirement specified in the URS is verified through specific test cases. 

    In this sense, qualification is more likely to be a documentation-driven, structured and checklist-based approach, focusing on verifying that vendor-supplied asset/entity meet predefined specifications. 

    Understanding Validation

    Validation, by contrast, focuses on ensuring that processes consistently produce outcomes that meet predetermined specifications.

    According to the FDA, validation is: “Establishing documented evidence which provides a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes.”

    Where qualification proves that an asset/entity is installed and functions correctly, validation demonstrates that the processes using that asset/entity are robust, repeatable, and compliant.  Furthermore, it is even more critical that “effective monitoring and control systems” are put in place for “process performance and product quality, thereby providing assurance of continued suitability and capability of processes”. This is a requirement as per ICHQ10 and continues to be for the last decade one of the most cited observations. The goal in validation and monitoring is not just compliance but smarter, data-driven decisions, continuous improvement being an important pillar. 

    Validation, therefore, is data-driven  and is focussed on data analysis providing the assurance that the process will consistently produce product whose quality meets predetermined specifications.

    Given that qualification and validation have very different approaches and end goals, is it possible to use one software tool to manage both requirements?

    Many software vendors market “all-in-one” applications as a one-stop solution. These apps promise to provide a unified platform for validation.  At first glance, the appeal of a unified system is undeniable. After all, a single tool that manages documentation, qualification, and validation activities across an entire organization sounds like a great solution.

    However, when the design requirement for a qualification activity has absolutely no relationship with what is to be done in validation and ongoing monitoring, how is it possible to combine the use cases?  

    The data type that a qualification management system main data type is textual information. User requirements are primarily captured as detailed text entries within structured tables, and supporting test scripts are also documented largely in text form. While most data centers around descriptive narratives—such as specifications, acceptance criteria, and rationales—numeric data appears mainly when recording process parameters during process qualification (PQ) for equipment. This emphasis on text ensures that every requirement and its verification are clearly documented for traceability, auditability, and regulatory compliance.

    Validation and ongoing monitoring activities are fundamentally centered around the defined product specifications, attribute specifications, equipment process parameter ranges and how these are met. The primary data type handled in this context is numeric, as these processes often involve the collection and analysis of quantifiable results—such as, equipment process parameter range for a noted batch, attribute measured results—to demonstrate compliance with set limits or acceptance criteria. This numerical data provides objective evidence to verify that equipment operate within their approved specifications, and enables continuous, data-driven monitoring to promptly detect deviations or trends. While supporting documentation like SOP may include textual explanations or rationales, it is the structured numeric data that forms the backbone of validation and monitoring efficacy.

    Pharmaceutical regulators expect manufacturers to proactively show processes are in control, detect deviations, implement timely corrections, and continually improve processes to guarantee product safety and efficacy.  While qualification is an integral part of the process validation program and expects all entities/assets used in the product manufacture to be shown to be “fit for use”, the expectation is also timely access to real-time or trending data, making it easy to promptly identify deviations, detect process drifts, or generate automated alerts.

    So an  “all-in-one” application designed to aid in qualification and CSV, can only act as storage repository for files associated with process validation.  Such applications consider validation or ongoing process verification runs as static activities with no ability to let the data speak for itself.   These teams rely on time-consuming, error-prone manual reviews to collate and interpret data, increasing the risk of missed trends and delayed responses to quality issues. Furthermore, static documentation impedes data integration, reduces the potential for cross-functional collaboration, and hinders the effectiveness of continuous improvement initiatives—ultimately compromising regulatory compliance and the robust oversight expected in modern pharmaceutical manufacturing.

    Conclusions

    Ultimately, companies must weigh the true cost of investment, both in terms of efficiency and compliance risk, when selecting validation tools. It may be time for the industry to reconsider whether costly all-in-one solutions are necessary, or if more focused, built for purpose software solutions targeted toward manufacturing process would better serve their needs.

    ravi

    July 27, 2025
    paperless validation
    digital transformation, digitilization, paperless validation, pharmaceutical

Powering Quality from Lab to Label © 2025, Quascenta Pte. Ltd.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}